Suppr超能文献

点状气单胞菌聚羟基脂肪酸酯(PHA)合酶的体内进化:具有增强活性的修饰PHA合酶的分离与表征

In vivo evolution of the Aeromonas punctata polyhydroxyalkanoate (PHA) synthase: isolation and characterization of modified PHA synthases with enhanced activity.

作者信息

Amara A A, Steinbüchel A, Rehm B H A

机构信息

Institut für Mikrobiologie der Westfälischen Wilhelms-Universität Münster, Corrensstrasse 3, 48149 Münster, Germany.

出版信息

Appl Microbiol Biotechnol. 2002 Aug;59(4-5):477-82. doi: 10.1007/s00253-002-1035-3. Epub 2002 Jun 22.

Abstract

In vivo random mutagenesis of the polyhydroxyalkanoate (PHA) synthase gene from Aeromonas punctata was performed employing the mutator strain Escherichia coli XL1-Red. About 200,000 mutants were screened on Nile red-containing medium and five mutants with enhanced fluorescence were selected. Four of these mutants exhibited enhanced in vivo and in vitro PHA synthase activity. Mutant M1, which carried the single mutation F518I, showed a five-fold increase in specific PHA synthase activity, whereas the corresponding mediated PHA accumulation increased by 20%, as compared with the wild-type PHA synthase. Mutant M2, which carried the single mutation V214G, showed a two-fold increase in specific PHA synthase activity and PHA accumulation only increased by 7%. Overall, the in vitro activities of the overproducing mutants ranged from 1.1- to 5-fold more than the wild-type activity, whereas the amounts of accumulated PHA ranged over 107-126% of that of the wild type. Moreover, all mutants mediated synthesis of PHAs with an increased weight average molar mass, but the molar fractions of 3-hydroxybutyrate and 3-hydroxyhexanoate remained almost constant. In vivo random mutagenesis proved to be a versatile tool to isolate mutants exerting improved properties with respect to PHA biosynthesis.

摘要

利用诱变菌株大肠杆菌XL1-Red对点状气单胞菌的聚羟基脂肪酸酯(PHA)合酶基因进行体内随机诱变。在含尼罗红的培养基上筛选了约200,000个突变体,选择了五个荧光增强的突变体。其中四个突变体在体内和体外均表现出增强的PHA合酶活性。携带单突变F518I的突变体M1的PHA合酶比活性增加了五倍,而与野生型PHA合酶相比,相应介导的PHA积累增加了20%。携带单突变V214G的突变体M2的PHA合酶比活性增加了两倍,而PHA积累仅增加了7%。总体而言,高产突变体的体外活性比野生型活性高1.1至5倍,而PHA的积累量为野生型的107-126%。此外,所有突变体介导合成的PHA重均摩尔质量增加,但3-羟基丁酸酯和3-羟基己酸酯的摩尔分数几乎保持不变。体内随机诱变被证明是一种通用工具,可用于分离在PHA生物合成方面具有改进特性的突变体。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验